Total Funding
38
43
Total FundingGrant raised
Growth Score
-27 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
153749
Immunovia is a diagnostics company that focuses on the early detection of pancreatic cancer through blood-based testing.
- Patrik Dahlen: Chief Executive Officer
- Karl Stone: Chief Operating Officer
About the Company
Immunovia is a diagnostics company specializing in the early detection of pancreatic cancer. Immunovia conducts clinical trials and validation studies to ensure the accuracy and reliability of their tests. The company collaborates with medical institutions and research centers globally to validate its diagnostic tests and bring them to market. By
focusing on early detection, Immunovia aims to significantly impact the treatment and management of pancreatic cancer, potentially improving survival rates. The company's innovative approach to using blood-based biomarkers could pave the way for early detection strategies in other cancers and complex diseases.
